{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:25:46Z","timestamp":1791239146280,"version":"4.1.0"},"reference-count":59,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objective: Bullous Pemphigoid (BP) is a well-recognized autoimmune subepidermal blistering disease. However, its occurrence following allogeneic hematopoietic stem cell transplantation (HSCT) is extremely rare. The objective of this study is to systematically review the available data on BP following an allogeneic HSCT with focus on treatment options. Methods: A systematic review of studies evaluating BP following allogeneic HSCT, incorporating a highly treatment-resistant case from our graft-versus-host disease (GvHD) dermatology clinic, of a 47-year-old patient, notable as the only reported instance of BP following HSCT in a patient with chronic lymphocytic leukemia (CLL) that transformed into diffuse large B-cell lymphoma (DLBCL) and GvHD due to HSCT. The review yielded 15 publications that met the eligibility criteria. Including our case, a total of 16 cases were analyzed. Results: Nearly all patients (14\/16) in this review had chronic GvHD due to their HSCT. Twelve patients were males, and six were of Japanese origin. The mean age for BP diagnosis was 38 years (a range of 5\u201367). On average, BP developed one year post-HSCT. The most common treatment for BP in these patients was prednisolone, with the majority experiencing complete resolution of symptoms. Conclusions: BP following HSCT is an exceptionally rare condition with an unclear underlying mechanism.<\/jats:p>","DOI":"10.3390\/jcm14124068","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T06:46:01Z","timestamp":1749451561000},"page":"4068","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bullous Pemphigoid as a Manifestation of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Report of a Novel Case"],"prefix":"10.3390","volume":"14","author":[{"given":"Sapir","family":"Glazer Levavi","sequence":"first","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 49100, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Yeshurun","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 49100, Israel"},{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9973-639X","authenticated-orcid":false,"given":"Pia","family":"Raanani","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 49100, Israel"},{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mor","family":"Frisch","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 49100, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9250-8351","authenticated-orcid":false,"given":"Meital","family":"Oren-Shabtai","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 49100, Israel"},{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-9587","authenticated-orcid":false,"given":"Lev","family":"Pavlovsky","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 49100, Israel"},{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mimouni","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 49100, Israel"},{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Aronovich","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 49100, Israel"},{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K Guidelines for the Management of Bullous Pemphigoid Initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"110694","DOI":"10.1016\/j.intimp.2023.110694","article-title":"Immune Cells in Pemphigus Vulgaris and Bullous Pemphigoid: From Pathogenic Roles to Targeting Therapies","volume":"123","author":"Yuan","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic Stem-Cell Transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-Host Disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood-2017-08-801001","article-title":"Antibodies Targeting Surface Membrane Antigens in Patients with Chronic Graft-versus-Host Disease","volume":"130","author":"Wang","year":"2017","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1468-3083.2009.03480.x","article-title":"Basement Membrane Antibodies in Sera of Haematopoietic Cell Recipients Are Associated with Graft-versus-host Disease","volume":"24","author":"Hofmann","year":"2010","journal-title":"Acad. Dermatol. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Moro, F., Fania, L., Sinagra, J.L.M., Salemme, A., and Di Zenzo, G. (2020). Bullous Pemphigoid: Trigger and Predisposing Factors. Biomolecules, 10.","DOI":"10.3390\/biom10101432"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1111\/jdv.19548","article-title":"Risk of de Novo Bullous Pemphigoid and Pemphigus Following Transplantation: A Global Wide-scale Cohort Study","volume":"38","author":"Kasperkiewicz","year":"2024","journal-title":"Acad. Dermatol. Venereol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1007\/s12325-024-02810-3","article-title":"Study Design of a Phase 2\/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT","volume":"41","author":"Murrell","year":"2024","journal-title":"Adv. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jdermsci.2020.05.010","article-title":"Genetic Predisposition to Bullous Pemphigoid","volume":"100","author":"Zhang","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00007890-198609000-00022","article-title":"DEVELOPMENT OF BULLOUS PEMPHIGOLD AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION Report of a Case","volume":"42","author":"Ueda","year":"1986","journal-title":"Transplantation"},{"key":"ref_12","first-page":"1367","article-title":"Bullous pemphigoid following graft-versus-host reaction after bone marrow allograft","volume":"17","author":"Lacour","year":"1988","journal-title":"Presse Med."},{"key":"ref_13","first-page":"377","article-title":"Bullous Pemphigoid Associated with Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation","volume":"10","author":"Delbaldo","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81-c","DOI":"10.1001\/archderm.135.1.81-c","article-title":"Tense Blisters After Bone Marrow Transplantation","volume":"135","author":"Kikuchi","year":"1999","journal-title":"Arch. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bmt.1703654","article-title":"Combination Treatment of Bullous Pemphigoid with Anti-CD20 and Anti-CD25 Antibodies in a Patient with Chronic Graft-versus-Host Disease","volume":"30","author":"Szabolcs","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2336\/nishinihonhifu.66.269","article-title":"A Case of Bullous Pemphigoid Associated with Graft Versus Host Disease","volume":"66","author":"Nagai","year":"2004","journal-title":"Nishinihon J. Dermatol."},{"key":"ref_17","first-page":"1823","article-title":"Bullous Pemphigoid after Allogeneic Bone Marrow Transplantation","volume":"46","author":"Kawasuji","year":"2004","journal-title":"Rinsho Derma"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaad.2006.10.986","article-title":"Bullous Pemphigoid Positive for Anti-BP180 and Anti-Laminin 5 Antibodies in a Patient with Graft-vs-Host Disease","volume":"56","author":"Izumi","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2340\/00015555-1676","article-title":"Detection of Apoptotic Keratinocytes in a Case of Bullous Pemphigoid Developed after Graft-versus-Host Disease","volume":"94","author":"Yoneda","year":"2014","journal-title":"Acta Derm. Venerol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/ped.12561","article-title":"Bullous Pemphigoid after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"57","author":"Kato","year":"2015","journal-title":"Pediatr. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1111\/bjd.15763","article-title":"Image Gallery: Juvenile Cutaneous Chronic Graft-versus-host Disease Presenting as Bullous Pemphigoid","volume":"177","author":"Haber","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jdcr.2020.08.035","article-title":"Autoimmune Bullous Disease in Skin of Color: A Case Series","volume":"6","author":"Tamazian","year":"2020","journal-title":"JAAD Case Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1111\/1346-8138.16008","article-title":"Case of Pemphigoid with Antibodies to BP180 C-terminal Domain and A3 Subunit of Laminin-332 Associated with Chronic Graft-versus-host Disease","volume":"48","author":"Kawashima","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D329562401","article-title":"Anti-Laminin 332 Antibodies in Graft-versus-Host Disease-Associated Bullous Pemphigoid after Allogeneic Peripheral Blood Stem Cell Transplantation","volume":"29","author":"Hida","year":"2023","journal-title":"Dermatol. Online J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yan, T., and Zhang, Z. (2023). Adaptive and Innate Immune Pathogenesis of Bullous Pemphigoid: A Review. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1144429"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1182\/blood-2017-11-784017","article-title":"B-Cell Targeting in Chronic Graft-versus-Host Disease","volume":"131","author":"Zeiser","year":"2018","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Khoder, A., Alsuliman, A., Basar, R., Sobieski, C., Kondo, K., Alousi, A.M., Szydlo, R., Muftuoglu, M., Shaim, H., and Apperley, J.F. (2017). Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01937"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.bbmt.2006.08.043","article-title":"Cutaneous Manifestations of Chronic Graft-versus-Host Disease","volume":"12","author":"Hymes","year":"2006","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Vi\u010di\u0107, M., Hla\u010da, N., Ka\u0161telan, M., Brajac, I., Soto\u0161ek, V., and Prpi\u0107 Massari, L. (2023). Comprehensive Insight into Lichen Planus Immunopathogenesis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24033038"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/odi.14142","article-title":"Immune Mechanisms in Oral Lichen Planus","volume":"29","author":"Thornhill","year":"2023","journal-title":"Oral. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Schinner, J., Cunha, T., Mayer, J.U., H\u00f6rster, S., Kind, P., Didona, D., Keber, C., Hertl, M., Worzfeld, T., and Juratli, H.A. (2023). Skin-Infiltrating T Cells Display Distinct Inflammatory Signatures in Lichen Planus, Bullous Pemphigoid and Pemphigus Vulgaris. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1203776"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Maronese, C.A., Cassano, N., Genovese, G., Foti, C., Vena, G.A., and Marzano, A.V. (2022). The Intriguing Links between Psoriasis and Bullous Pemphigoid. J. Clin. Med., 12.","DOI":"10.3390\/jcm12010328"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.humimm.2019.03.003","article-title":"B Cells in Chronic Graft-versus-Host Disease","volume":"80","author":"McManigle","year":"2019","journal-title":"Hum. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1182\/blood-2008-10-161638","article-title":"The Role of B Cells in the Pathogenesis of Graft-versus-Host Disease","volume":"114","author":"Hallek","year":"2009","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e21746","DOI":"10.1096\/fj.202100145R","article-title":"Neutrophil Extracellular Traps Contribute to Immune Dysregulation in Bullous Pemphigoid via Inducing B-Cell Differentiation and Antibody Production","volume":"35","author":"Fang","year":"2021","journal-title":"FASEB J."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Berkani, N., Joly, P., Golinski, M.-L., Colliou, N., Lim, A., Larbi, A., Riou, G., Caillot, F., Bernard, P., and Bedane, C. (2019). B-Cell Depletion Induces a Shift in Self Antigen Specific B-Cell Repertoire and Cytokine Pattern in Patients with Bullous Pemphigoid. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-40203-7"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0923-1811(02)00067-1","article-title":"Th1, Th2 and Th3 Cytokines in the Pathogenesis of Bullous Pemphigoid","volume":"30","author":"Giomi","year":"2002","journal-title":"J. Dermatol. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual Blockade of IL-4 and IL-13 with Dupilumab, an IL-4R\u03b1 Antibody, Is Required to Broadly Inhibit Type 2 Inflammation","volume":"75","author":"Allinne","year":"2020","journal-title":"Allergy"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"111157","DOI":"10.1016\/j.intimp.2023.111157","article-title":"Long-Term Efficacy and Safety of Dupilumab for Severe Bullous Pemphigoid: A Prospective Cohort Study","volume":"125","author":"Huang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_40","first-page":"90","article-title":"Targeting Cytokines in GVHD Therapy","volume":"2","author":"Kumar","year":"2017","journal-title":"J. Immunol. Res. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1346-8138.1991.tb03091.x","article-title":"Immunohistochemistry of Cutaneous Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation","volume":"18","author":"Girolomoni","year":"1991","journal-title":"J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.4049\/jimmunol.120.5.1485","article-title":"Deposition of IgM and Complement at the Dermoepidermal Junction in Acute and Chronic Cutaneous Graft-vs-Host Disease in Man","volume":"120","author":"Tsoi","year":"1978","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2230.1976.tb01445.x","article-title":"Skin Antibodies in Bone Marrow Transplanted Patients","volume":"1","author":"Saurat","year":"1976","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_44","first-page":"803","article-title":"Chronic graft-versus-host disease presenting as bullous lesions","volume":"99","year":"2008","journal-title":"Actas Dermosifiliogr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2133.1996.tb03611.x","article-title":"Comparative Sensitivity of Indirect Immunofluorescence to Immunoblot Assay for the Detection of Circulating Antibodies to Bullous Pemphigoid Antigens 1 and 2","volume":"135","author":"Ghohestani","year":"1996","journal-title":"Br. J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40257-023-00832-1","article-title":"Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update","volume":"25","author":"Karakioulaki","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Huang, D., Zhang, Y., Kong, L., Lu, J., and Shi, Y. (2023). Janus Kinase Inhibitors in Autoimmune Bullous Diseases. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1220887"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.bmt.1704808","article-title":"Successful Anti-CD20 Antibody Treatment of Pemphigus Foliaceus after Unrelated Cord Blood Transplantation","volume":"35","author":"Herr","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"ref_49","first-page":"139","article-title":"Epidermolysis Bullosa Acquisita, a Rare Late Complication of Allogeneic Bone Marrow Transplantation?","volume":"9","author":"Burger","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.135.9.1091","article-title":"Antiepiligrin Cicatricial Pemphigoid: An. Underdiagnosed Entity Within the Spectrum of Scarring Autoimmune Subepidermal Bullous Diseases?","volume":"135","author":"Leverkus","year":"1999","journal-title":"Arch. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1532\/IJH97.05061","article-title":"Cicatricial Pemphigoid of the Oropharynx after Allogeneic Stem Cell Transplantation for Relapsed Follicular Lymphoma","volume":"82","author":"Aisa","year":"2005","journal-title":"Int. J. Hematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000243807","article-title":"Mucous Membrane Pemphigoid with Antibodies to the Beta(3) Subunit of Laminin 332 in a Patient with Acute Myeloblastic Leukemia and Graft-versus-Host Disease","volume":"219","author":"Takahara","year":"2009","journal-title":"Dermatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/bmt.2009.98","article-title":"Mucous Membrane Pemphigoid Following Reduced Intensity Conditioning Allogeneic Haematopoietic SCT for Biphenotypic Leukaemia","volume":"45","author":"Mahmood","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1346-8138.2010.01185.x","article-title":"Mucous Membrane Pemphigoid with Antibodies to the \u03923 Subunit of Laminin 332","volume":"38","author":"Masunaga","year":"2011","journal-title":"J. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1684\/ejd.2013.2090","article-title":"Refractory Mucous Membrane Pemphigoid Which Developed after Allogeneic Stem Cell Transplantation and Was Successfully Treated with Rituximab","volume":"23","author":"Nishimura","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1111\/1346-8138.13977","article-title":"Anti-Laminin-332-Type Mucous Membrane Pemphigoid in a Patient with Adult T-Cell Leukemia\/Lymphoma and Graft-versus-Host Disease","volume":"44","author":"Baba","year":"2017","journal-title":"J. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/ijd.14027","article-title":"Epitope Spread in Chronic Mucosal GVHD: Mucous Membrane Pemphigoid Resolution with Rituximab","volume":"58","author":"Huff","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1468-3083.2004.01065.x","article-title":"Linear IgA Dermatosis in an Immunosuppressed Patient after Allogenic Bone Marrow Transplantation","volume":"18","author":"Schultewolter","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jdermsci.2017.07.012","article-title":"IgG4, Complement, and the Mechanisms of Blister Formation in Pemphigus and Bullous Pemphigoid","volume":"88","author":"Dainichi","year":"2017","journal-title":"J. Dermatol. Sci."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4068\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:48:42Z","timestamp":1760032122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14124068"],"URL":"https:\/\/doi.org\/10.3390\/jcm14124068","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]}}}